Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CNL Healthcare Properties (CHTH) EBIT Margin (2016 - 2025)

CNL Healthcare Properties (CHTH) has 14 years of EBIT Margin data on record, last reported at 11.11% in Q3 2025.

  • For Q3 2025, EBIT Margin rose 234.0% year-over-year to 11.11%; the TTM value through Sep 2025 reached 9.29%, up 170.0%, while the annual FY2024 figure was 8.45%, 410.0% up from the prior year.
  • EBIT Margin reached 11.11% in Q3 2025 per CHTH's latest filing, up from 10.56% in the prior quarter.
  • Across five years, EBIT Margin topped out at 11.95% in Q2 2024 and bottomed at 13.47% in Q4 2021.
  • Average EBIT Margin over 5 years is 4.97%, with a median of 6.26% recorded in 2023.
  • Peak YoY movement for EBIT Margin: tumbled -1408bps in 2021, then soared 1454bps in 2022.
  • A 5-year view of EBIT Margin shows it stood at 13.47% in 2021, then skyrocketed by 108bps to 1.06% in 2022, then skyrocketed by 104bps to 2.17% in 2023, then skyrocketed by 216bps to 6.86% in 2024, then skyrocketed by 62bps to 11.11% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 11.11% in Q3 2025, 10.56% in Q2 2025, and 8.85% in Q1 2025.